Document is current

Article History

Received: 1 February 2021

Revised: 23 April 2021

Accepted: 11 May 2021

First Online: 24 May 2021

Compliance with ethical standards

:

: HS: honoraria: AbbVie, Amgen, BMS, Celgene, Chugai, GSK, Janssen, Oncopeptides, Sanofi, Sebia, Takeda; travel, accommodations, expenses: Amgen, BMS, Celgene, Janssen, Sanofi. AE: honoraria: Janssen, Celgene, Takeda; consulting or advisory role: Janssen, Amgen, Celgene, Takeda, Sanofi; travel, accommodations, expenses: Janssen, Takeda, Celgene, Amgen, Novartis. MMe: consulting or advisory role: BMS, Amgen, Takeda; research funding: Takeda; travel, accommodations, expenses: Celgen, AMGEN, Takeda, Abbvie, Janssen. KM: no COI AB: no COI MHä: honoraria: Novartis, Amgen, Roche, Takeda; consulting or advisory role: Celgene. CJ: honoraria: Janssen, Celgene, Takeda; consulting or advisory role: Janssen, Amgen, Celgene, Takeda, Sanofi; travel, accommodations, expenses: Janssen, Takeda, Celgene, Amgen, Novartis EKM: honoraria: Janssen, Celgene, Takeda, GSK; consulting or advisory role: Janssen, Celgene, Takeda, GSK; research funding: Takeda; travel, accomodations, expenses: Janssen, Takeda, Celgene, Onyx, BMS, Mundipharma. UB: no COI IWB: research funding: Celgene, BMS, Janssen. CS: honoraria: BMS, Janssen, Celgene, Novartis, Amgen, Takeda; consulting or advisory role: BMS, Janssen, Celgene, Novartis, Amgen, Takeda; speakers bureau: Takeda; research funding: Takeda, Novartis; travel, accommodations, expenses: BMS, Janssen, Celgene, Novartis, Amgen, Takeda. DH: consulting or advisory role: I. Lamkap Bio AG. Discoveric AG; research funding: Celgene AG. Sanofi. Engmab AG; travel, accommodations, expenses: Celgene. AS: consulting or advisory role: I. Lamkap Bio AG. Discoveric AG; research funding: Celgene AG. Sanofi. Engmab AG. AJ: no COI MSR: consulting or advisory role, travel support: BMS, Amgen, Incyte, Takeda, Novartis, Janssen, AbbVie, Sanofi, Roche; Research Funding: Amgen, Novartis, Sanofi SPL: no COI BB: honoraria: Janssen-Cilag, GSK, Takeda. MMu: honoraria: Janssen, BMS, Takeda, Celgene, Amgen, GSK, Sanofi-Genzyme; consulting or advisory role: Janssen, BMS, Takeda, Celgene, Amgen, GSK; research funding: BMS, Incyte; travel, accomodations, expenses: Janssen, BMS, Takeda, Amgen. PB: consulting or advisory role: BMS, AMGEN, Roche, MSD; research funding: BMS; travel, accommodations, expenses: BMS. SF: consulting or advisory role: Amgen, BMS, Celgene, Sanofi, Janssen. H-WL: no COI KW: Grants from Amgen, Celgene, Sanofi, Janssen (all to the institution), honoraria and advisory board from Amgen, BMS, Celgene, Adaptive Biotech, Janssen, GSK, Karyopharm, Roche, Sanofi, Takeda, Oncopeptides. JD: consulting or advisory role: Celgene; speakers bureau: Celgene; travel, accommodations, expenses: Celgene. HG: Grants and/or provision of Investigational Medicinal Product: Amgen, BMS, Celgene, Chugai, Dietmar-Hopp-Foundation, Janssen, Johns Hopkins University, Sanofi. Research Support: Amgen, BMS, Celgene, Chugai, Janssen, Incyte, Molecular Partners, Merck Sharp and Dohme (MSD), Sanofi, Mundipharma GmbH, Takeda, Novartis. Advisory Boards: Adaptive Biotechnology, Amgen, BMS, Celgene, Janssen, Sanofi, Takeda. Honoraria: Amgen, BMS, Celgene, Chugai, GlaxoSmithKline (GSK), Janssen, Novartis, Sanofi.